Baku 1° C
BioNTech, Pfizer studying new COVID variant
Health
- 26 November, 2021
- 13:30
BioNTech and Pfizer said that experts are studying a new variant of coronavirus discovered in South Africa, more information is expected in two weeks, Report informs.
“We expect more laboratory data in two weeks at the latest,” BioNTech spokesman said, according to Agence France-Presse.
The company stressed that the data will help to understand whether the variant of coronavirus B.1.1.529 could “require a vaccine adjustment” by Pfizer/BioNTech in the event that it spreads worldwide.
Author
Latest News
20:57
Leyla Aliyeva meets with Afghan women's rights activist Zarqa Yaftali in Abu Dhabi
Foreign policy20:49
Simonyan denies shift in Armenia's foreign policy at expense of ties with Russia
Region20:16
Fitch assesses SOCAR ratings alongside 10 of world's largest oil and gas companies
Energy20:10
Photo
Azerbaijan's contribution to intercultural dialogue discussed in UN
Cultural policy19:53
Photo
Director of Heydar Aliyev School in Kahramanmaras thanks Azerbaijan for support
Region19:29
Trump says Ilham Aliyev and Pashinyan are 'two really good leaders'
Other countries19:17
Trump says US ramping up oil production to unprecedented levels
Other countries19:03
Media: Russia, US agree to observe new START terms for another six months
Other countries18:52